|
Bailen R, Pascual-Cascon MJ, Guerreiro M, Lopez-Corral L, Chinea A, Bermudez A, Sampol A, Heras I, Garcia-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, Lopez-Godino O, Martin-Calvo C, Fernandez-Caldas P, Marcos-Jubilar M, Sanchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Diez-Martin JL, Kwon M; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH). Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. PubMed PMID: 35108627.
AÑO: 2022; IF: 3.2
|
35108627
|
Bailen R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Valles A, Esquirol A, Fonseca M, Solan L, Sanchez-Vadillo I, Bautista G, Bento L, Lopez-Godino O, Perez-Martinez A, Torrent A, Zanabili J, Calbacho M, Moreno MA, Pascual-Cascon MJ, Guerra-Dominguez L, Chinea A, Garcia-Cadenas I, Lopez-Corral L, Boix-Giner F, Lopez Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernandez-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PubMed PMID: 37304258; PubMed Central PMCID: PMC10250708.
AÑO: 2023; IF: 5.7
|
|
Pinana JL, Heras I, Aiello TF, Garcia-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, Garcia-Vidal C, Arroyo I, Soler-Espejo E, Lopez-Corral L, Avendano-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernandez-Medina L, Gonzalez-Santillana C, Morell J, Hernandez-Rivas JA, Rodriguez-Galvez P, Mico-Cerda M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PubMed PMID: 37896843; PubMed Central PMCID: PMC10612015.
AÑO: 2023; IF: 3.8
|
|
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204.
AÑO: 2024; IF: 5.0
|
|
Pinana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garcia-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendano-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R, Solano C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Front Oncol. 2024 Jun 19;14:1389345. doi: 10.3389/fonc.2024.1389345. eCollection 2024. PubMed PMID: 39015498; PubMed Central PMCID: PMC11250586.
AÑO: 2024; IF: 3.3
|